GIPM
STIM icon

G2 Investment Partners Management’s Neuronetics STIM Stock Holding History

G2 Investment Partners Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-681,461
Closed -$1.23M – 84
2024
Q2 		$1.23M Buy
681,461
+24,228
+4% +$69.9K 0.32% 64
2024
Q1 		$3.13M Buy
657,233
+583,937
+797% +$2.05M 0.83% 42
2023
Q4 		$213K Buy
+73,296
New +$116K 0.06% 83
2022
Q3 		– Sell
-143,960
Closed -$462K – 91
2022
Q2 		$462K Sell
143,960
-33,617
-19% -$97.6K 0.15% 66
2022
Q1 		$538K Sell
177,577
-92,423
-34% -$312K 0.13% 65
2021
Q4 		$1.2M Sell
270,000
-120,000
-31% -$588K 0.21% 65
2021
Q3 		$2.56M Sell
390,000
-56,968
-13% -$546K 0.44% 48
2021
Q2 		$7.16M Sell
446,968
-185,176
-29% -$2.56M 1.18% 33
2021
Q1 		$7.82M Buy
632,144
+488,936
+341% +$7.5M 1.24% 34
2020
Q4 		$1.59M Buy
143,208
+124,015
+646% +$932K 0.29% 54
2020
Q3 		$93K Buy
+19,193
New +$72.8K 0.02% 76

Other funds holding STIM

KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

G2 Investment Partners Management's STIM Position: Q3 2024 in Review

G2 Investment Partners Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 681,461 shares — an estimated $1.23M sold.

G2 Investment Partners Management first reported a position in STIM in Q3 2020 and held it in 11 quarters. The position peaked at $7.82M in Q1 2021. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • G2 Investment Partners Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • G2 Investment Partners Management sold 681,461 Neuronetics shares in Q3 2024, an estimated $1.23M.
  • G2 Investment Partners Management first reported a position in Neuronetics in Q3 2020 and held it in 11 quarters.
  • G2 Investment Partners Management's Neuronetics position peaked at $7.82M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on G2 Investment Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.